97 related articles for article (PubMed ID: 2934080)
1. [Clinicoimmunological values of measurement of IgG-Fc receptor positive T cells in the patients with malignant brain tumors].
Yoshida S; Hara N; Takai N; Saito T; Tanaka R
No To Shinkei; 1985 Nov; 37(11):1073-8. PubMed ID: 2934080
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-immunological evaluation of T cells bearing IgG Fc receptors in brain tumor patients].
Kawamoto K; Kawakami K; Oka N; Nishimura T; Ouchi M; Okuyama T; Miki K; Kawamura Y; Matsumura H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1606-11. PubMed ID: 3161455
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of tumor specific immunological response in the patients with malignant brain tumors by the mixed lymphocyte-tumor cell reaction].
Yoshida S; Takai N; Ono K; Saito T; Tanaka R
No To Shinkei; 1988 Nov; 40(11):1067-73. PubMed ID: 2975495
[TBL] [Abstract][Full Text] [Related]
4. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
Itagaki E; Toge T; Tanada M; Hamamoto S; Seto Y; Kohno H; Hattori T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the immunosuppressive mechanism in patients with malignant brain tumors].
Yoshida S
No To Shinkei; 1985 Dec; 37(12):1137-43. PubMed ID: 3879181
[TBL] [Abstract][Full Text] [Related]
6. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
[TBL] [Abstract][Full Text] [Related]
7. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
[TBL] [Abstract][Full Text] [Related]
8. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.
Graziano RF; Fanger MW
J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735
[TBL] [Abstract][Full Text] [Related]
9. [Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
Matsuhisa T
No To Shinkei; 1995 May; 47(5):466-73. PubMed ID: 7786623
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies of Fc receptors for IgG on resting and activated mouse T lymphocytes using different methods].
Hückel C; Sandor M; Erdei A; Jensen HL; Brock J; Rychly J; Gergely J
Allerg Immunol (Leipz); 1986; 32(1):47-56. PubMed ID: 2940850
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas.
Elliott L; Brooks W; Roszman T
J Natl Cancer Inst; 1987 May; 78(5):919-22. PubMed ID: 3106694
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of activated lymphocytes and antigen-present macrophage in human brain tumors using double immunofluorescence staining].
Kunishio K; Mishima N; Matsuhisa T; Tsuno K; Maeshiro H; Shigematsu H; Matsumi N; Matsumoto K; Furuta T; Nishimoto A
No To Shinkei; 1989 Dec; 41(12):1195-201. PubMed ID: 2697376
[TBL] [Abstract][Full Text] [Related]
13. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
14. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory abnormalities in chronic lymphocytic leukemia. I. Correlations of immunoregulatory subpopulations with stage of disease.
Keller RH; Blake DG; Lyman S; Siebenlist R
J Clin Lab Immunol; 1981 Nov; 6(3):201-9. PubMed ID: 6461766
[TBL] [Abstract][Full Text] [Related]
16. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
[TBL] [Abstract][Full Text] [Related]
17. Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.
Titus JA; Perez P; Kaubisch A; Garrido MA; Segal DM
J Immunol; 1987 Nov; 139(9):3153-8. PubMed ID: 2959724
[TBL] [Abstract][Full Text] [Related]
18. Antigenic characterization of a T-CLL with heteroantisera and monoclonal antibodies: evidence for the T cell lineage of an Ia-positive, Fc-IgG--positive, suppressor-cell subpopulation.
Strong DM; Pandolfi F; Slease RB; Budd JE; Woody JN
J Immunol; 1981 Jun; 126(6):2205-8. PubMed ID: 6453158
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma bearing T cells in non-Hodgkin lymphoma.
Keller RH; Libnoch J; Patrick CW; Blake DG; Choi H; Hanson G
Diagn Immunol; 1983; 1(1):27-32. PubMed ID: 6238746
[TBL] [Abstract][Full Text] [Related]
20. Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity.
Lang NP; Ortaldo JR; Bonnard GD; Herberman RB
J Natl Cancer Inst; 1982 Aug; 69(2):339-43. PubMed ID: 6180205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
